Xconomy National

Archives

by in

Entry	Author	Date	Location
SD Life Sciences Roundup: Illumina, Applied Proteomics, & Tocagen	Bruce V. Bigelow	02/10/12	San Diego
Vaccines Top the List of 2010 Innovations	Larry Corey	12/27/10	Seattle
Antigenics, and its UCSF Champion, Stick With Immune Booster For Brain Cancer	Luke Timmerman	10/25/10	Boston
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News	Luke Timmerman	10/07/10	Seattle
Seattle Children’s Moves in at Prominent Biotech Address as Targeted Genetics Moves Out	Luke Timmerman	08/18/10	Seattle
Kaleetan Seeks to Stand on Dendreon’s Shoulders, With Immune Therapy for Cancer	Luke Timmerman	08/09/10	Seattle
Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M	Luke Timmerman	12/23/09	Boston
Hutch Snaps Up $8.9M in Donations	Luke Timmerman	12/07/09	Seattle
New Life Sciences Startup Shows UCSD Technology Can Boost Immune Response to Cancer in Mice	Bruce V. Bigelow	10/14/09	San Diego
MabVax Raising $4 Million	Bruce V. Bigelow	09/02/09	San Diego
Dendreon Saga Heads Toward Climax, As Cancer Drug Aims to Prove It Prolongs Lives	Luke Timmerman	04/03/09	Seattle
CG Therapeutics, Immune-Booster For Cancer, Recruits Dendreon Vets, New CEO	Luke Timmerman	03/10/09	Seattle
Microsoft and EMC Get Secure, PATH Puts $3M Into Bird Flu, Amazon Closes Book on Abe, & More Seattle-Area Deals News	Gregory T. Huang	12/09/08	Seattle
‘Hutch’ Raises $2.2M at Holiday Gala	Luke Timmerman	12/08/08	Seattle
Dendreon Gives Update on Clinical Trials of Prostate Cancer Drug	Gregory T. Huang	08/12/08	Seattle
Page 1 of 1